Company: INMB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001213900-25-041072
Chunk: 130

Company: Inmune Bio, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 4
Chunk 130
---

    0001711754
    
      us-gaap:RetainedEarningsMember

    2024-03-31

    0001711754

    2024-03-31

    0001711754
    
      us-gaap:EmployeeStockOptionMember

    2025-01-01
    2025-03-31

    0001711754
    
      us-gaap:EmployeeStockOptionMember

    2024-01-01
    2024-03-31

    0001711754
    
      us-gaap:WarrantMember

    2025-01-01
    2025-03-31

    0001711754
    
      us-gaap:WarrantMember

    2024-01-01
    2024-03-31

    0001711754
    
      country:AU

    2025-01-01
    2025-03-31

    0001711754
    
      country:AU

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:GreatOrmondStreetHospitalMember

    2025-03-31

    0001711754
    
      inmb:GreatOrmondStreetHospitalMember

    2024-12-31

    0001711754
    
      srt:ScenarioForecastMember

    2025-06-26
    2025-06-26

    0001711754
    
      inmb:MilestonePaymentPhaseOneInitiationMember
      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      inmb:MilestonePaymentPhaseTwoInitiationMember
      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      inmb:MilestonePaymentPhaseThreeInitiationMember
      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      inmb:MilestonePaymentNdaEmaFilingMember
      inmb:INKmuneLicenseAgreement